Atherosclerosis: A link between lipid intake and protein tyrosine nitration

Lipid Insights

Volumn 2 1, Issue , 2008, Pages 75-88

  Upmacis, Rita K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67149117913     PISSN: None     EISSN: 11786353     Source Type: Journal    
DOI: 10.4137/lpi.s1030     Document Type: Review

References (115)

1. +- ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation. Circ. Res., 90:1114-21.
2. Anitschkow, N. 1933. Experimental atherosclerosis in animals, New York,. Macmillan.
3. Ascherio, A., Weisskopf, M.G., O'reilly, E.J., Jacobs, E.J., Mccullough, M.L., Calle, E.E., Cudkowicz, M. and Thun, M.J. 2005. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann. Neurol., 57:104-10.
4. Auerbach, O., Hammond, E.C. and Garfinke, L. 1965. Smoking in Relation to Atherosclerosis of Coronary Arteries. N. Engl. J. Med., 273:775-9.
5. Bang, H.O., Dyerberg, J. and Hjorne, N. 1976. Composition of Food Consumed by Greenland Eskimos. Acta. Med. Scand., 200:69-73.
6. Beckman, J. 1996. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol., 9:836-44.
7. Beckman, J.S. and Crow, J.P. 1993. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans., 21:330-4.
8. Beckmann, J.S., Ye, Y.Z., Anderson, P.G., Chen, J., Accavitti, M.A., Tarpey, M.M. and White, C.R. 1994. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochem- istry. Biol. Chem. Hoppe. Seyler, 375:81-8.
9. Blankenberg, S., Luc, G., Ducimetiere, P., Arveiler, D., Ferrieres, J., Amouyel, P., Evans, A., Cambien, F., Tiret, L. and Grp, P.S. 2003. Interleukin-18 and the risk of coronary heart disease in European men-The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation, 108:2453-9.
10. Boekholdt, S.M., Peters, R.J.G., De Maat, M.P.M., Zwinderman, A.H., Van Der Wall, E.E., Reitsma, P.H., Jukema, J.W. and Kastelein, J.J.P. 2004. Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovas- cular events. Am. Heart J., 147:181-6.
11. Boekholdt, S.M., Peters, R.J.G., Hack, C.E., Day, N.E., Luben, R., Bingham, S.A., Wareham, N.J., Reitsma, P.H. and Khaw, K.T. 2004. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women-The EPIC-Norfolk prospective population study. Arterioscler. Thromb. Vasc. Biol., 24:1503-8.
12. Boolell, M., Gepiattee, S., Gingell, J.C. and Allen, M.J. 1996. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br. J. Urol., 78:257-61.
13. Borbely, A., Toth, A., Edes, I., Virag, L., Papp, J.G., Varro, A., Paulus, W.J., Van Der Velden, J., Stienen, G.J.M. and Papp, Z. 2005. Peroxynitrite- induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells. Cardiovasc. Res., 67:225-33.
14. Breslow, J.L. 2006. n-3 fatty acids and cardiovascular disease. Am. J. Clin. Nutr., 83:1477S-82S.
15. Buttery, L.D., Springall, D.R., Chester, A.H., Evans, T.J., Standfield, E.N., Parums, D.V., Yacoub, M.H. and Polak, J.M. 1996. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest., 75:77-85.
16. Calder, P.C. 2001. Polyunsaturated fatty acids, inflammation, and immunity. Lipids, 36:1007-24.
17. Danik, J.S., Rifai, N., Buring, J.E. and Ridker, P.M. 2006. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA, 296:1363-70.
18. Daugherty, A., Manning, M.W. and Cassis, L.A. 2000. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest., 105:1605-12.
19. Davis, J.A. and Wiesel, B.H. 1955. The Treatment of Angina Pectoris with a Nitroglycerin Ointment. American Journal of the Medical Sciences, 230:259-63.
20. Deeb, R.S., Hao, G., Gross, S.S., Laine, M., Qiu, J.H., Resnick, B., Barbar, E.J., Hajjar, D.P. and Upmacis, R.K. 2006. Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H-2 synthase-1 by peroxynitrite. J. Lipid Res., 47:898-911.
21. Deeb, R.S., Resnick, M.J., Mittar, D., Mccaffrey, T., Hajjar, D.P. and Upmacis, R.K. 2002. Tyrosine nitration in prostaglandin H(2) synthase. J. Lipid Res., 43:1718-26.
22. Deeb, R.S., Shen, H., Gamss, C., Gavrilova, T., Summers, B. D., Kraemer, R., Hao, G., Gross, S. S., Laine, M., Maeda, N., Hajjar, D. P. and Upmacis, R. K. 2006. Inducible nitric oxide synthase mediates prosta- glandin h2 synthase nitration and suppresses eicosanoid production. Am. J. Pathol., 168:349-62.
23. Detmers, P. A., Hernandez, M., Mudgett, J., Hassing, H., Burton, C., Mundt, S., Chun, S., Fletcher, D., Card, D. J., Lisnock, J., Weikel, R., Bergstrom, J. D., Shevell, D. E., Hermanowski-Vosatka, A., Sparrow, C. P., Chao, Y. S., Rader, D. J., Wright, S. D. and Pure, E. 2000. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J. Immunol., 165:3430-5.
24. Furchgott, R.F. and Jothianandan, D. 1991. Endothelium-Dependent and Endothelium-Independent Vasodilation Involving Cyclic-Gmp- Relaxation Induced by Nitric-Oxide, Carbon-Monoxide and Light. Blood Vessels, 28:52-61.
25. Geleijnse, J.M., Giltay, E.J., Grobbee, D.E., Donders, A.R.T. and Kok, F.J. 2002. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens., 20:1493-99.
26. Gow, A.J., Duran, D., Malcolm, S. and Ischiropoulos, H. 1996. Effects of peroxynitriteinduced protein modifications on tyrosine phosphoryla- tion and degradation. FEBS Lett., 385:63-66.
27. Graham, A., Hogg, N., Kalyanaraman, B., O'leary, V., Darley-Usmar, V. and Moncada, S. 1993. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger recep- tor. FEBS Lett, 330:181-5.
28. Hajjar, D.P., Deeb, R.S. and Upmacis, R.K. 2006. Complex "cross talk" involving nitric oxide metabolites: Who's listening? Curr. Atheroscler. Rep., 8:347-8.
29. Harris, W.S. 1997. n-3 Fatty acids and serum lipoproteins: Human studies. Am. J. Clin. Nutr., 65:S1645-S1654.
30. Harris, W.S., Rambjor, G.S., Windsor, S.L. and Diederich, D. 1997. n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am. J. Clin. Nutr., 65:459-64.
31. Hazen, S.L., Zhang, R., Shen, Z., Wu, W., Podrez, E.A., Macpherson, J.C., Schmitt, D., Mitra, S.N., Mukhopadhyay, C., Chen, Y., Cohen, P.A., Hoff, H.F. and Abu-Soud, H.M. 1999. Formation of nitric oxide- derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo. Circ. Res., 85:950-8.
32. Heinzel, B., John, M., Klatt, P., Bohme, E. and Mayer, B. 1992. Ca2+/ calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem. J., 281 (Pt 3), 627-30.
33. Hochman, J.S., Alexander, J.H., Reynolds, H.R., Stebbins, A.L., Dzavik, V., Harrington, R.A., De Werf, F.V. and Investigators, T. 2007. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock-The TRIUMPH randomized controlled trial. JAMA, 297:1657-66.
34. Hsiai, T.K., Hwang, J., Barr, M.L., Correa, A., Hamilton, R., Alavi, M., Rouhanizadeh, M., Cadenas, E. and Hazen, S.L. 2007. Hemodynam- ics influences vascular peroxynitrite formation: Implication for low-density lipoprotein apo-B-100 nitration. Free Radic. Biol. Med., 42:519-29.
35. Huang, P.L., Huang, Z.H., Mashimo, H., Bloch, K.D., Moskowitz, M.A., Bevan, J.A. and Fishman, M.C. 1995. Hypertension in Mice Lacking the Gene for Endothelial Nitric-Oxide Synthase. Nature, 377:239-42
36. Huie, R.E. and Padmaja, S. 1993. The reaction of NO with superoxide. Free Radic. Res. Commun., 18:195-9.
37. Illingworth, D.R. and Tobert, J.A. 2001. HMG-CoA reductase inhibitors. Adv. Protein Chem., 56(56):77-114.
38. Irie, Y., Saeki, M., Kamisaki, Y., Martin, E. and Murad, F. 2003. Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immu- noreactivity in proteins. Proc. Natl. Acad. Sci. U.S.A., 100:5634-9.
39. Johnson, T.B. 1915. Studies on nitrated proteins IV The identification of 3-nitrotyrosine among the products of hydrolysis of nitrated fibroin. J. Am. Chem. Soc., 37:2598-603.
40. Johnson, T.B. and Kohmann, E.F. 1915. Studies on nitrated proteins I The determination of the structure of nitrotyrosine. J. Am. Chem. Soc., 37:1863-84.
41. Kannel, W.B., Castelli, W.P., Gordon, T. and Mcnamara, P.M. 1971. Serum Cholesterol, Lipoproteins, and Risk of Coronary Heart Disease- Framingham Study. Ann. Intern. Med., 74:1-12.
42. Khan, J., Brennan, D.M., Bradley, N., Gao, B.R., Bruckdorfer, R. and Jacobs, M. 1998. 3-nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem. J., 330:795-801.
43. Khot, U.N., Khot, M.B., Bajzer, C.T., Sapp, S.K., Ohman, E.M., Brener, S.J., Ellis, S.G., Lincoff, A.M. and Topol, E.J. 2003. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA, 290:898-904.
44. Knapp, H.R. 1997. Dietary fatty acids in human thrombosis and hemostasis. Am. J. Clin. Nutr., 65:S1687-98.
45. Knowles, R.G. and Moncada, S. 1994. Nitric-Oxide Synthases in Mammals. Biochem. J., 298:249-58.
46. Koeck, T., Fu, X.M., Hazen, S.L., Crabb, J.W., Stuehr, D.J. and Aulak, K.S. 2004. Rapid and selective oxygen-regulated protein tyrosine denitra- tion and nitration in mitochondria. J. Biol. Chem., 279:27257-62.
47. Kuhlencordt, P.J., Chen, J., Han, F., Astern, J. and Huang, P.L. 2001. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation, 103:3099-104.
48. Landino, L.M., Crews, B.C., Timmons, M.D., Morrow, J.D. and Marnett, L.J. 1996. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. U.S.A., 93:15069-74.
49. Leaf, A., Kang, J.X., Xiao, Y.F. and Billman, G.E. 2003. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation, 107:2646-52.
50. Leary, T. 1934. Experimental atherosclerosis in the rabbit compared with human (coronary) atherosclerosis. Arch. Pathol., 17:453-92.
51. Leeuwenburgh, C., Hardy, M.M., Hazen, S.L., Wagner, P., Oh-Ishi, S., Steinbrecher, U.P. and Heinecke, J.W. 1997. Reactive nitrogen inter- mediates promote low density lipoprotein oxidation in human ath- erosclerotic intima. J. Biol. Chem., 272:1433-6.
52. Liao, J.K. and Laufs, U. 2005. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol., 45:89-118.
53. Libby, P., Ridker, P.M. and Maseri, A. 2002. Inflammation and atheroscle- rosis. Circulation, 105:1135-43.
54. Lokuta, A.J., Maertz, N.A., Meethal, S.V., Potter, K.T., Kamp, T.J., Valdivia, H.H. and Haworth, R.A. 2005. Increased nitration of sarcoplasmic reticulum Ca2+ -ATPase in human heart failure. Circulation, 111:988-95.
55. Macmahon, S., Peto, R., Cutler, J., Collins, R., Sorlie, P., Neaton, J., Abbott, R., Godwin, J., Dyer, A. and Stamler, J. 1990. Blood-Pressure, Stroke, and Coronary Heart-Disease. 1. Prolonged Differences in Blood-Pressure-Prospective Observational Studies Corrected for the Regression Dilution Bias. Lancet, 335:765-74.
56. Macmicking, J.D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D.S., Trumbauer, M., Stevens, K., Xie, Q. W., Sokol, K., Hutchinson, N. and et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell., 81:641-50.
57. Mctaggart, F. and Jones, P. 2008. Effects of statins on high-density lipoproteins: A potential contribution to cardiovascular benefit. Cardiovasc. Drugs Ther., 22:321-38.
58. Meng, W., Ayata, C., Waeber, C., Huang, P.L. and Moskowitz, M.A. 1998. Neuronal NOScGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice. Am. J. Physiol. Heart Circ. Physiol., 43:H411-H415.
59. Miettinen, M., Turpeinen, O., Karvonen, M.J., Elosuo, R. and Paavilainen, E. 1972. Effect of Cholesterol-Lowering Diet on Mortality from Coronary Heart-Disease and Other Causes-12-Year Clinical Trial in Men and Women. Lancet, 2:835-8.
60. Mihm, M.J., Coyle, C.M., Schanbacher, B.L., Weinstein, D.M. and Bauer, J.A. 2001. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc. Res., 49:798-807.
61. Mozaffarian, D., Katan, M.B., Ascherio, A., Stampfer, M.J. and Willett, W.C. 2006. Medical progress-Trans. fatty acids and cardiovascular disease. N. Engl. J. Med., 354:1601-13.
62. Nissen, S.E., Tuzcu, E.M., Schoenhagen, P., Brown, B.G., Ganz, P., Vogel, R.A., Crowe, T., Howard, G., Cooper, C.J., Brodie, B., Grines, C.L., Demaria, A.N. and Investigators, R. 2004. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis-A randomized controlled trial. JAMA, 291:1071-80.
63. Nowak, P., Kolodziejczyk, J. and Wachowicz, B. 2004. Peroxynitrite and fibrinolytic system: The effect of peroxynitrite on plasmin activity. Molecular and Cellular Biochemistry, 267:141-6.
64. Ohara, Y., Peterson, T.E. and Harrison, D.G. 1993. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest, 91:2546-51.
65. Ohshima, H., Friesen, M., Brouet, I. and Bartsch, H. 1990. Nitrotyrosine as a New Marker for Endogenous Nitrosation and Nitration of Proteins. Food Chem. Toxicol., 28:647-52.
66. Pacher, P., Beckman, J.S. and Liaudet, L. 2007. Nitric oxide and peroxyni- trite in health and disease. Physiol. Rev., 87:315-424.
67. Parastatidis, I., Thomson, L., Fries, D.M., Moore, R.E., Tohyama, J., Fu, X.M., Hazen, S., Heijnen, H.F.G., Dennehy, M.K., Liebler, D.C., Rader, D.J. and Ischiropoulos, H. 2007. Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I-deficient mice. Circ. Res., 101:368-76.
68. Pauling, L. 1970. Vitamin C and the common cold, Freeman, W.H. and Company.
69. Peluffo, G. and Radi, R. 2007. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc. Res., 75:291-302.
70. Pennathur, S., Bergt, C., Shao, B.H., Byun, J., Kassim, S.Y., Singh, P., Green, P.S., Mcdonald, T.O., Brunzell, J., Chait, A., Oram, J.F., O'brien, K., Geary, R.L. and Heinecke, J.W. 2004. Human athero- sclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J. Biol. Chem., 279:42977-83.
71. Pignatelli, B., Li, C.Q., Boffetta, P., Chen, Q.P., Ahrens, W., Nyberg, F., Mukeria, A., Bruske-Hohlfeld, I., Fortes, C., Constantinescu, V., Ischiropoulos, H. and Ohshima, H. 2001. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res., 61:778-84.
72. Pirro, M., Schillaci, G., Mannarino, M.R., Savarese, G., Vaudo, G., Siepi, D., Paltriccia, R. and Mannarino, E. 2007. Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia. Nutrition Metabolism and Cardiovascular Diseases, 17:436-41.
73. Pou, S., Keaton, L., Surichamorn, W. and Rosen, G.M. 1999. Mechanism of superoxide generation by neuronal nitric-oxide synthase. J. Biol. Chem., 274:9573-80.
74. Rader, J.R. and Daugherty, A. 2008. Translating molecular discoveries into new therapies for atheroscleorsis. Nature, 451:904-13.
75. Ridker, P.M. 2008. The time for cardiovascular inflammation reduction trials has arrived-How low to go for hsCRP? Arterioscler. Thromb. Vascu. Biol., 28:1222-4.
76. Ridker, P.M., Fonseca, F., Genest, J., Gotto, A.M., Kastelein, J. J.P., Khurmi, N.S., Koenig, W., Libby, P., Lorenzatti, A.J., Nordestgaard, B.G., Shepherd, J., Willerson, J.T., Glynn, R.J. and Grp, J.T.S. 2007. Base- line characteristics of participants in the JUPITER. trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated highsensitivity C-reactive protein. Am. J. Cardiol., 100:1659-64.
77. Ridker, P.M., Manson, J.E., Buring, J.E., Shih, J., Matias, M. and Hennekens, C.H. 1999. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA, 281:1817-21.
78. Ridker, P.M., Willich, S.N., Muller, J.E. and Hennekens, C.H. 1991. Aspirin, Platelet-Aggregation, and the Circadian Variation of Acute Thrombotic Events. Chronobiology International, 8:327-35.
79. Roberts, W.C. 2006. Atherosclerosis: Its Causes and Its Prevention. Am. J. Cardiol., 98:1550-5.
80. Rueckschloss, U., Quinn, M.T., Holtz, J. and Morawietz, H. 2002. Dose-dependent regulation of NAD(P)H oxidase expression b angiotensin II in human endothelial cells-Protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol., 22:1845-51.
81. Salonen, R.M., Nyyssonen, K., Kaikkonen, J., Porkkala-Sarataho, E., Voutilainen, S., Rissanen, T.H., Tuomainen, T.P., Valkonen, V.P., Ristonmaa, U., Lakka, H.M., Vanharanta, M., Salonen, J.T. and Poulsen, H.E. 2003. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression-The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study. Circulation, 107:947-53.
82. Schildknecht, S., Heinz, K., Daiber, A., Hamacher, J., Kavakli, C., Ullrich, V. and Bachschmid, M. 2005. Autocatalytic tyrosine nitration of pros- taglandin endoperoxide synthase-2 in LPS-stimulated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun., 340:318-25.
83. Schmidt, P., Youhnovski, N., Daiber, A., Balan, A., Arsic, M., Bachschmid, M., Przybylski, M. and Ullrich, V. 2003. Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J. Biol. Chem., 278:12813-9.
84. Shishehbor, M.H., Aviles, R.J., Brennan, M.L., Fu, X.M., Goormastic, M., Pearce, G.L., Gokce, N., Keaney, J.F., Penn, M.S., Sprecher, D.L., Vita, J.A. and Hazen, S.L. 2003. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA, 289:1675-80.
85. Smythe, C.D.W., Skinner, V.O., Bruckdorfer, K.R., Haskard, D.O. and Landis, R.C. 2003. The state of macrophage differentiation determines the TNF alpha response to nitrated lipoprotein uptake. Atherosclerosis, 170:213-21.
86. Souza, J.M., Choi, I., Chen, Q.P., Weisse, M., Daikhin, E., Yudkoff, M., Obin, M., Ara, J., Horwitz, J. and Ischiropoulos, H. 2000. Proteolytic degradation of tyrosine nitrated proteins. Arch. Biochem. Biophys., 380:360-6.
87. Stamler, J., Vaccaro, O., Neaton, J.D. and Wentworth, D. 1993. Diabetes, Other Risk-Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16:434-44.
88. Stampfer, M.J., Hu, F.B., Manson, J.E., Rimm, E.B. and Willett, W.C. 2000. Primary prevention of coronary heart disease in women through diet and lifestyle. N. Engl. J. Med., 343:16-22.
89. Stuehr, D.J. 1997. Structure-function aspects in the nitric oxide synthases. Annu. Rev. Pharmacol. Toxicol, 37:339-59.
90. Thomson, L., Christie, J., Vadseth, C., Lanken, P.N., Fu, X.M., Hazen, S.L. and Ischiropoulos, H. 2007. Identification of immunoglobulins that recognize 3-nitrotyrosine in patients with acute lung injury after major trauma. Am. J. Respir. Cell Mol. Biol., 36:152-7.
91. Traber, M.G., Frei, B. and Beckman, J.S. 2008. Vitamin E revisited: do new data validate benefits for chronic disease prevention? Curr. Opin. Lipidol., 19:30-8.
92. Troxler, M., Naseem, K.M. and Homer-Vanniasinkam, S. 2004. Increased nitrotyrosine production in patients undergoing abdominal aortic aneurysm repair. Br. J. Surg., 91:1146-52.
93. Upmacis, R.K., Crabtree, M.J., Deeb, R.S., Shen, H., Lane, P.B., Benguigui, L.E.S., Maeda, N., Hajjar, D.P. and Gross, S.S. 2007. Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase. Am. J. Physiol. Heart Circ. Physiol., 293: H2878-H2887.
94. Upmacis, R.K., Deeb, R.S. and Hajjar, D.P. 1999. Regulation of prostaglandin H2 synthase activity by nitrogen oxides. Biochemistry, 38:12505-13.
95. Upmacis, R.K., Deeb, R.S. and Hajjar, D.P. 2001. Role of nitrogen oxides on eicosanoid production during atherosclerosis: understanding the controversies. Curr. Atheroscler. Rep, 3:181-2.
96. Upmacis, R.K., Deeb, R.S. and Hajjar, D.P. 2006. Oxidative alterations of cyclooxygenase during atherogenesis. Prostaglandins Other Lipid Mediat., 80:1-14.
97. Upmacis, R.K., Deeb, R.S., Resnick, M.J., Lindenbaum, R., Gamss, C., Mittar, D. and Hajjar, D.P. 2004. Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol., 286:C1271-C1280.
98. Vadseth, C., Souza, J.M., Thomson, L., Seagraves, A., Nagaswami, C., Scheiner, T., Torbet, J., Vilaire, G., Bennett, J.S., Murciano, J.C., Muzykantov, V., Penn, M.S., Hazen, S.L., Weisel, J.W. and Ischiropoulos, H. 2004. Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J. Biol. Chem., 279:8820-6.
99. Valagussa, F., Franzosi, M.G., Geraci, E., Mininni, N., Nicolosi, G.L., Santini, M., Tavazzi, L., Vecchio, C., Marchioli, R., Bomba, E., Chieffo, C., Maggioni, A.P., Schweiger, C., Tognoni, G., Barzi, F., Flamminio, A.V., Marfisi, R.M., Olivieri, M., Pera, C., Polidoro, A., Santoro, E., Zama, R., Pagliaro, L., Correale, E., Del Favero, A., Loi, U., Marubini, E., Campolo, L., Casari, A., Di Minno, G., Donati, M. B., Galli, M., Gattone, M., Garattini, S., Mancini, M., Marino, P., Santoro, G.M., Scardulla, C., Specchia, G., Cericola, A., DI Gregorio, D., DI Mascio, R., Levantesi, G., Mantini, L., Mastrogiuseppe, G., Tucci, C., Mocarelli, P., Baldinelli, R., Ceriotti, F., Colonna, A., Cortese, C., Fortunato, G., Franzini, C., Gonano, F., Graziani, M.S. and Investigators, G-P. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet, 354:447-55.
100. Van Der Loo, B., Labugger, R., Skepper, J.N., Bachschmid, M., Kilo, J., Powell, J.M., Palacios-Callender, M., Erusalimsky, J.D., Quaschning, T., Malinski, T., Gygi, D., Ullrich, V. and Luscher, T.F. 2000. Enhanced peroxynitrite formation is associated with vascular aging. J. Exp. Med., 192:1731-43.
101. Vasquez-Vivar, J., Kalyanaraman, B., Martasek, P., Hogg, N., Masters, B.S., Karoui, H., Tordo, P. and Pritchard, K.A., Jr. 1998. Superoxide gen- eration by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. U.S.A., 95:9220-5.
102. Verschuren, W.M.M., Jacobs, D.R., Bloemberg, B.P.M., Kromhout, D., Menotti, A., Aravanis, C., Blackburn, H., Buzina, R., Dontas, A.S., Fidanza, F., Karvonen, M.J., Nedeljkovic, S., Nissinen, A. and Toshima, H. 1995. Serum Total Cholesterol and Long-Term Coronary Heart-Disease Mortality in Different Cultures-25-Year Follow-up of the 7-Countries Study. JAMA, 274:131-6.
103. Wever, R.M., Van Dam, T., Van Rijn, H.J., De Groot, F. and Rabelink, T.J. 1997. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem. Biophys. Res. Commun., 237:340-4.
104. Wright, M.E., Lawson, K.A., Weinstein, S.J., Pietinen, P., Taylor, P.R., Virtamo, J. and Albanes, D. 2006. Higher baseline serum concentra- tions of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Clin. Nutr., 84:1200-7.
105. Xia, Y., Tsai, A.L., Berka, V. and Zweier, J.L. 1998. Superoxide generation from endothelial nitricoxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J. Biol. Chem., 273:25804-8.
106. Xia, Y. and Zweier, J.L. 1997. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl. Acad. Sci. U.S.A., 94:6954-8.
107. Xu, S. Q., Ying, J., Jiang, B.B., Guo, W., Adachi, T., Sharov, V., Lazar, H., Menzoian, J., knyushko, T.V., Bigelow, D., Schoneich, C. and Cohen, R.A. 2006. Detection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging. Am. J. Physiol. Heart Circ. Physiol., 290:H2220-H2227.
108. Yamakura, F., Taka, H., Fujimura, T. and Murayama, K. 1998. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J. Biol. Chem., 273:14085-9.
109. Yamasaki, K., Edington, H.D.J., Mcclosky, C., Tzeng, E., Lizonova, A., Kovesdi, I., Steed, D.L. and Billiar, T.R. 1998. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral- mediated iNOS gene transfer. J. Clin. Invest., 101:967-71.
110. Yokoyama, M. 2004. Oxidant stress and atherosclerosis. Curr. Opin. Pharmacol., 4:110-5.
111. Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., Sleight, P. and Study, H.O.P.E. 2000 Vitamin E supplementation and cardiovascular events in high-risk patients. N. Engl. J. Med., 342:154-60.
112. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., Dagenais, G. and Study, H.O.P.E. 2000 Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N. Engl. J. Med., 342:145-53.
113. Zheng, L.M., Nukuna, B., Brennan, M.L., Sun, M.J., Goormastic, M., Settle, M., Schmitt, D., Fu, X.M., Thomson, L., Fox, P.L., Ischiropoulos, H., Smith, J.D., Kinter, M. and Hazen, S.L. 2004. Apolipoprotein A-I is a selective target for myeloperoxidasecatalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest., 114:529-41.
114. Zou, M., Martin, C. and Ullrich, V. 1997. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol. Chem., 378:707-13.
115. Zou, M. H., Leist, M. and Ullrich, V. 1999. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am. J. Pathol., 154:1359-65.